A drug with the SMILES N#Cc1ccccc1S(=O)(=O)N1CCN(S(=O)(=O)c2ccc(Br)c(C(=O)O)c2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 12.161\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
N#Cc1ccccc1S(=O)(=O)N1CCN(S(=O)(=O)c2ccc(Br)c(C(=O)O)c2)CC1
N#Cc1ccccc1S(=O)(=O)N1CCN(S(=O)(=O)c2ccc(Br)c(C(=O)O)c2)CC1
2-bromo-5-[4-(2-cyanophenyl)sulfonylpiperazin-1-yl]sulfonylbenzoic acid